Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Quality of Life in Patients With Post-Sepsis Syndrome

NCT: NCT07889804 · NOT_YET_RECRUITING

NCT IDNCT07889804
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2029-11-01
SponsorEfferon JSC (INDUSTRY)
First posted
Last updated

Brief Summary

The aim of the study is to assess health status and quality of life during the post-sepsis period using patient-reported outcome measures. Patients will be classified into two groups according to treatment received during hospitalization for sepsis or septic shock: those who received standard-of-care treatment alone and those who additionally received Efferon® LPS hemoadsorption. The study will compare post-sepsis outcomes between the two groups over a 12-month follow-up period.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑